Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in Kurdistan treated with an antibiotic combination including Imipenem-Relebactam and Rifabutin
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),Pulmonary and Respiratory Medicine
Reference21 articles.
1. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections;Alffenaar;Clin Pharmacokinet,2021
2. Aziz DB, Go ML, Dick T. Rifabutin suppresses inducible clarithromycin resistance in mycobacterium abscessus by blocking induction of whiB7 and erm41. Antibiotics 2020;9. Doi: 10.3390/antibiotics9020072.
3. Rifabutin is active against Mycobacterium abscessus complex;Aziz;Antimicrob Agents Chemother,2017
4. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing;Bastian;Antimicrob Agents Chemother,2011
5. Daniel-Wayman S, Shallom S, Azeem N, Olivier KN, Zelazny AM, Prevots DR. Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus. ERJ Open Res 2019;5. Doi: 10.1183/23120541.00154-2018.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Characteristics and Outcomes of Extrapulmonary Nontuberculous Mycobacterial Infections in a Tertiary-Care Hospital: A Retrospective Study;Journal of Clinical Medicine;2024-07-26
2. Combination of Imipenem-Cilastatin-Relebactam and Amoxicillin in the Antibiotic Regimen in Two Cases of Mycobacterium abscessus Lung Infection;Cureus;2024-07-22
3. In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates;Microbiology Spectrum;2024-07-02
4. Aesthetic medical tourism in Colombia: opportunity for the economic development of the country;Salud, Ciencia y Tecnología;2024-01-01
5. Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs;Frontiers in Cellular and Infection Microbiology;2023-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3